Lawrence Nathan Shulman, MD
Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Abramson Cancer Center
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine
South Pavilion, 12-105
Philadelphia, PA 19104
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine
South Pavilion, 12-105
Philadelphia, PA 19104
Education:
B.A. (Organic Chemistry)
Syracuse University, 1971.
M.D. (Medicine)
Harvard Medical School, 1975.
Permanent linkB.A. (Organic Chemistry)
Syracuse University, 1971.
M.D. (Medicine)
Harvard Medical School, 1975.
Description of Clinical Expertise
Lawrence N. Shulman, MD, is the Associate Director for Special Projects of the Abramson Cancer Center at the University of Pennsylvania, and Director of the Center for Global Cancer Medicine.Dr. Shulman is immediate past Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. He is the former Chair of the American Society of Clinical Oncology Quality of Care Committee and the Commission on Cancer’s Quality Integration Committee. In this regard, Dr. Shulman serves as Senior Oncology Advisor to the non-profit organization Partners In Health (PIH). The PIH mission includes the establishment of national cancer treatment programs with the Ministries of Health in Rwanda, Lesotho, and Haiti, programs for which he plays a seminal leadership role. He sits on the Vice Chancellor’s Advisory Council for Rwanda’s University for Global Health Equity. In addition, he helps to lead the development of the national oncology program in Botswana through the Botswana-UPenn Partnership.
Dr. Shulman is a former member of ASCO’s International Affairs Committee and their Task Force on Global Oncology as an Academic Career. He led the World Health Organization’s review and revision of their Essential Medicines for Cancer from 2014-2017.
He received his MD from Harvard Medical School, and trained in Hematology and Oncology at the Beth Israel Hospital in Boston, MA.
Description of Other Expertise
Dr Shulman has a long history of development and implementation of information technology solutions to improve the efficiency and safety of cancer care delivery. He continues to develop tools to improve data capture in electronic health records (EHRs) and to utilize those and patient reported outcomes to understand treatment and outcomes of real world patients in the US.Description of Research Expertise
His research includes innovations in cancer care delivery, both in the US and in resource constrained settings, including Rwanda, Lesotho, Botswana and Haiti.Selected Publications
Jacobs L, Shulman L: Cardio-Oncology Care Delivery for All Patients With Cancer Within Academic and Community Settings. J Am Coll Cardiol CardioOnc. 2024, 0 (0) doi: 10.1016/j.jaccao.2023.10.010 2024.Martei YM, Mokokwe L, Ngwako N, Kebuang K, Setlhako DI, Gabaatlhole G, Baaitse B, Segadimo T, Shulman LN, Barg F, Gaolebale BE. : Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study. BMJ Open. 2024 Jan 30;14(1):e073867. doi: 10.1136/bmjopen-2023-073867. PMID: 38296302; PMCID: PMC10828869 2024.
Singh AP, Balogh EP, Carlson RW, Huizinga MM, Malin BA, Melamed A, Meropol NJ, Pisano ED, Winn RA, Yabroff KR, Shulman LN. : Re-Envisioning Electronic Health Records to Optimize Patient-Centered Cancer Care, Quality, Surveillance, and Research. JCO Oncol Pract. 2024 Aug 5:OP2400260. doi: 10.1200/OP.24.00260. Online ahead of print.PMID: 39102623 2024.
Manz CR, Schriver E, Ferrell WJ, Williamson J, Wakim J, Khan N, Kopinsky M, Balachandran M, Chen J, Patel MS, Takvorian SU, Shulman LN, Bekelman JE, Barnett IJ, Parikh RB: Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial. J Med Internet Res. 2024 May 17;26:e51059. doi: 10.2196/51059.PMID: 38758583 2024.
Bourlon MT, Bhatt AS, Lopes G, Asirwa FC, Eniu AE, Loehrer PJ, Shulman LN, Close J, Von Roenn J, Tibbits M, Pyle D, Gralow JR: Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO. JCO Glob Oncol. 2024 Apr;10:e2300157. doi: 10.1200/GO.23.00157. PMID: 38603655 2024.
Lau-Min KS, Marini J, Shah NK, Pucci D, Blauch AN, Cambareri C, Mooney B, Agarwal P, Johnston C, Schumacher RP, White K, Gabriel PE, Rosin R, Jacobs LA, Shulman LN. : Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine. JCO Oncol Pract. 2024 Jan 18:OP2300365. doi: 10.1200/OP.23.00365. Epub ahead of print. PMID: 38237102 2024.
Boffa DJ, Nelson H, Mullett T, Opelka F, Turner PL, Shulman LN. : Privacy on the Road to Personalized Medicine. J Natl Compr Canc Netw. 2024 Jan 4:1-5. doi: 10.6004/jnccn.2023.7101. Epub ahead of print. PMID: 38176100. 2024.
Takvorian SU, Gabriel P, Wileyto EP, Blumenthal D, Tejada S, Clifton ABW, Asch DA, Buttenheim AM, Rendle KA, Shelton RC, Chaiyachati KH, Fayanju OM, Ware S, Schuchter LM, Kumar P, Salam T, Lieberman A, Ragusano D, Bauer AM, Scott CA, Shulman LN, Schnoll R, Beidas RS, Bekelman JE, Parikh RB. : Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial. JAMA Netw Open. 2024 Jul 1;7(7):e2418639. doi: 10.1001/jamanetworkopen.2024.18639.PMID: 38949813 2024.
Marmarelis ME, Scholes DG, McWilliams TL, Hwang WT, Kosteva J, Costello MR, Sun L, Singh AP, Lau-Min KS, Doucette A, Gabriel PE, Martella AO, Roy MA, Thompson JC, Cohen RB, Dougherty DW, Shulman LN, Langer CJ, Bekelman JE, Carpenter EL, Aggarwal C. : Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial. JCO Oncol Pract. 2024 Jul 3:OP2400070. doi: 10.1200/OP.24.00070. Online ahead of print.PMID: 38959441 2024.
DeBoer RJ, Ho A, Mutoniwase E, Nguyen C, Umutesi G, Bigirimana JB, Nsabimana N, Van Loon K, Shulman LN, Triedman SA, Cubaka VK, Shyiramere C. : Ethical dilemmas in prioritizing patients for scarce radiotherapy resources. BMC Med Ethics. 2024 Jan 31;25(12). doi: 10.1186/s12910-024-01005-3 2024.